Doctors say Vytorin-cancer link can't be ruled out
(AP) -- Results from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with great caution until more is known, editors of a leading medical journal urged Tuesday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Cancer: Landmark study opens door to new cancer, aging treatments

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!
Digg It

Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback
are you tired of your lifestyle now~!! why not to have a change now~!!
Join Gothicloving.c o m to date someone for sharing your interests, your problems, your music and your spirit or even the perfect darkchylde to bring back to your lair. yah~!! come on to share the new lifestyle~!!!